Latest Nan Fung Group Holdings Ltd Stock Portfolio
Nan Fung Group Holdings Ltd Performance:
2025 Q2: 3.53%YTD: -2.53%2024: 3.71%
Performance for 2025 Q2 is 3.53%, and YTD is -2.53%, and 2024 is 3.71%.
About Nan Fung Group Holdings Ltd and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Nan Fung Group Holdings Ltd reported an equity portfolio of $63.4 Millions as of 30 Jun, 2025.
The top stock holdings of Nan Fung Group Holdings Ltd are HRMY, ILMN, . The fund has invested 18.4% of it's portfolio in HARMONY BIOSCIENCES HLDGS IN and 17.9% of portfolio in ILLUMINA INC.
The fund managers got completely rid off VERONA PHARMA PLC (VRNA), ZAI LAB LTD (ZLAB) and MIRUM PHARMACEUTICALS INC (MIRM) stocks. They significantly reduced their stock positions in REPLIMUNE GROUP INC (REPL). Nan Fung Group Holdings Ltd opened new stock positions in BOLT BIOTHERAPEUTICS INC (BOLT) and BOLT PROJS HLDGS INC.
The top stock holdings of Nan Fung Group Holdings Ltd are HRMY, ILMN, . The fund has invested 18.4% of it's portfolio in HARMONY BIOSCIENCES HLDGS IN and 17.9% of portfolio in ILLUMINA INC.
The fund managers got completely rid off VERONA PHARMA PLC (VRNA), ZAI LAB LTD (ZLAB) and MIRUM PHARMACEUTICALS INC (MIRM) stocks. They significantly reduced their stock positions in REPLIMUNE GROUP INC (REPL). Nan Fung Group Holdings Ltd opened new stock positions in BOLT BIOTHERAPEUTICS INC (BOLT) and BOLT PROJS HLDGS INC.
Nan Fung Group Holdings Ltd Annual Return Estimates Vs S&P 500
Our best estimate is that Nan Fung Group Holdings Ltd made a return of 3.53% in the last quarter. In trailing 12 months, it's portfolio return was 3.71%.
New Buys
| Ticker | $ Bought |
|---|---|
| bolt biotherapeutics inc | 336,662 |
| bolt projs hldgs inc | 114,484 |
New stocks bought by Nan Fung Group Holdings Ltd
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| replimune group inc | -84.62 |
Nan Fung Group Holdings Ltd reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| geron corp | -2,183,940 |
| bolt projs hldgs inc | -249,513 |
| climb bio inc | -565,658 |
| zai lab ltd | -9,167,820 |
| tourmaline bio inc | -3,454,040 |
| xenon pharmaceuticals inc | -5,321,200 |
| kalvista pharmaceuticals inc | -1,783,180 |
| verona pharma plc | -9,395,880 |
Nan Fung Group Holdings Ltd got rid off the above stocks
Sector Distribution
Nan Fung Group Holdings Ltd has about 77.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 77.9 |
| Others | 22.1 |
Market Cap. Distribution
Nan Fung Group Holdings Ltd has about 30.3% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 29.4 |
| LARGE-CAP | 24.3 |
| UNALLOCATED | 22.1 |
| MID-CAP | 17.3 |
| MEGA-CAP | 6 |
Stocks belong to which Index?
About 66.7% of the stocks held by Nan Fung Group Holdings Ltd either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 42.4 |
| Others | 33.3 |
| S&P 500 | 24.3 |
Nan Fung Group Holdings Ltd Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Nan Fung Group Holdings Ltd
Nan Fung Group Holdings Ltd has 20 stocks in it's portfolio. About 87.5% of the portfolio is in top 10 stocks. HRMY proved to be the most loss making stock for the portfolio. ILMN was the most profitable stock for Nan Fung Group Holdings Ltd last quarter.
Last Reported on: 13 Aug, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| HRMY | harmony biosciences hldgs in | 18.37 | 368,665 | 11,649,800 | unchanged | 0.00 | ||
Historical Trend of HARMONY BIOSCIENCES HLDGS IN Position Held By Nan Fung Group Holdings LtdWhat % of Portfolio is HRMY?:Number of HRMY shares held:Change in No. of Shares Held: | ||||||||
| ILMN | illumina inc | 17.93 | 119,196 | 11,372,500 | unchanged | 0.00 | ||
| oculis holding ag | 15.75 | 514,702 | 9,990,370 | unchanged | 0.00 | |||
| INCY | incyte corp | 6.34 | 59,022 | 4,019,400 | unchanged | 0.00 | ||
| BGNE | beone medicines ltd | 6.00 | 15,722 | 3,805,820 | unchanged | 0.00 | ||
| MDGL | madrigal pharmaceuticals inc | 5.66 | 11,872 | 3,592,940 | unchanged | 0.00 | ||
| RXRX | recursion pharmaceuticals in | 5.30 | 664,610 | 3,362,930 | unchanged | 0.00 | ||
| RYTM | rhythm pharmaceuticals inc | 4.89 | 49,120 | 3,103,890 | unchanged | 0.00 | ||
| ascendis pharma a/s | 3.70 | 13,600 | 2,347,360 | unchanged | 0.00 | |||
| LAB | standard biotools inc | 3.56 | 1,883,180 | 2,259,820 | unchanged | 0.00 | ||
| ACAD | acadia pharmaceuticals inc | 3.50 | 102,984 | 2,221,360 | unchanged | 0.00 | ||
| argenx se | 2.43 | 2,800 | 1,543,420 | unchanged | 0.00 | |||
| KYMR | kymera therapeutics inc | 2.12 | 30,875 | 1,347,380 | unchanged | 0.00 | ||
| RVMD | revolution medicines inc | 1.12 | 19,253 | 708,318 | unchanged | 0.00 | ||
| REPL | replimune group inc | 0.93 | 63,719 | 591,950 | reduced | -84.62 | ||
| BCYC | bicycle therapeutics plc | 0.76 | 68,943 | 479,154 | unchanged | 0.00 | ||
| BOLT | bolt biotherapeutics inc | 0.53 | 58,347 | 336,662 | new | |||
| TRDA | entrada therapeutics inc | 0.52 | 49,082 | 329,831 | unchanged | 0.00 | ||
| RANI | rani therapeutics hldgs inc | 0.40 | 493,584 | 253,653 | unchanged | 0.00 | ||
| bolt projs hldgs inc | 0.18 | 40,597 | 114,484 | new | ||||
